Embody Inc.
Embody is pioneering the next generation regenerative platform with novel collagen- based biofabrication techniques and products for sports medicine. Embody is pioneering the next generation regenerative platform for the repair of tendon and ligament injuries with novel collagen-based bio-fabrication techniques and products for the fast-growing sports medicine market. Founded in 2014, the company is developing unique biomaterials with an initial focus on orthopedic applications including Achilles, rotator cuff and knee ligament repair. Embody, Inc., a privately-held medical device company developing novel collagen-based technologies for soft tissue injury and repair, announced today the expansion and clinical use cases of TAPESTRY Biointegrative Implant in the U.S. market.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Nationally (across the country)
Mission
Embody’s mission is to improve quality of life for traumatic and sports injury patients by providing regenerative products that promote faster healing and restore pre-injury performance.
Advanced Approach
Utilizing a dynamic blend of established, proprietary, and innovative scientific techniques we are developing regenerative collagen-based implants that will resorb into the body, improving the outcome for the over 2 million patients annually affected by soft tissue injuries in the United States.